Living dossier
Alzheimer's disease
A living Archypedia dossier connecting source-backed reporting, context and new developments about Alzheimer's disease.
Evidence timeline
Coverage as it developed
Newest first. Every entry retains its own source ledger and publication history.
-
Alzheimer's blood test predicts risk of cognitive decline a decade early
Researchers found that a blood biomarker could help identify Alzheimer’s risk in cognitively healthy adults, though experts advise against routine screening.
Health · 592 words -
New Imaging Technology Tracks Cellular Roots of Alzheimer's, Parkinson
University of Houston researchers are using advanced imaging to track CTR1 protein dynamics, identifying how cellular copper regulation may influence neurodegenerative disease.
Health · 616 words -
Up to 45% of dementia risk can be prevented, delayed: WHO
Updated WHO guidelines shift the perception of dementia from an inevitable consequence of aging to a manageable public health priority.
Health · 634 words -
Up to 45% of dementia risk can be prevented or delayed — WHO
The World Health Organization has updated its international guidelines, identifying 14 modifiable risk factors that influence the development of dementia. These findings provide a framework for public health policy and individual cognitive health management.
Health · 600 words -
Weizmann Institute Alzheimer's immunotherapy clears Phase 1 safety trial
A Phase 1b trial of the immunotherapy IBC-Ab002 has successfully met safety endpoints, marking a potential shift in treating Alzheimer's as a systemic immune disorder.
Health · 668 words -
Up to 45% of dementia risk can be prevented or delayed: WHO
The World Health Organization has released updated guidelines identifying modifiable health and lifestyle factors that can prevent or delay dementia. Researchers are also exploring new diagnostic blood tests and experimental drug therapies to address cognitive decline.
Health · 715 words -
Biogen tau-targeting Alzheimer’s drug slows cognitive decline in study
Researchers have unveiled mid-stage trial results for diranersen, an experimental drug that reduces abnormal tau production in Alzheimer’s patients.
Business · 689 words -
Mediterranean diet reduces Alzheimer's risk, especially for genetic carriers
A study tracking over 26,000 participants over three decades found that a Mediterranean diet is linked to cognitive benefits, particularly for APOE4 carriers.
Health · 737 words